Boutin et al. and Smith et al. concluded, after stage II of their single-center randomized studies, that administering IL-1 beta in mice led to the extension of cerebral ischemic lesions, and that mice with deficiency in IL-1 beta presented smaller volumes of cerebral infarction. Here, IL1B is linked to cerebral infarction.